Dorzolamide-timolol in Combination With Anti-vascular Endothelial Growth Factor Injections for Wet Age-related Macular Degeneration

NCT03034772 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Neovascular Age-related Macular Degeneration
Wet Macular Degeneration

Interventions

DRUG: Dorzolamide-timolol
OTHER: Artificial tears

Sponsor

Wills Eye

Collaborators

[object Object]